Lumox
PrivateLast Round
Grant
Jul 16, 2026
Total Funding Raised
$5.68M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Lumox operates in Healthcare & Life Sciences and is based in Utrecht. Its latest recorded funding round was a Grant round in July 2026.
Lumox is a biotechnology company that develops targeted photodynamic therapeutics for the selective destruction of cancer cells.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lumox Comparables
Compare Lumox with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cortalix B.V. | 44% | |
| Modulight Oyj | 41% | |
| GenLumina | 39% |
For institutional investors. Book with your work email.
Lumox Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 16, 2026 | ||||
| Grant | Jun 12, 2026 | ||||
| Grant | Sep 12, 2025 | ||||
| Grant | Jun 24, 2025 | ||||
| Grant | Oct 8, 2024 | ||||
Grant | Mar 28, 2024 |
For institutional investors. Book with your work email.
Lumox Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KWF Dutch Cancer Society | Grant |
| Philips Innovation Award | Grant |
| Utrecht Holdings | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 153% MoM.
- Jul 16, 2026
$5.13M grant from KWF Dutch Cancer Society
For institutional investors. Book with your work email.
Lumox Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Lumox's valuation, stock price, and market status.
Is Lumox a public or private company?
Lumox is a private company.
What is the current stock price of Lumox?
Lumox is a private company, so its shares have no public market price. Caplight tracks Lumox's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Lumox worth (valuation)?
Valuation information for Lumox is not publicly available.
Can I buy Lumox stock?
Lumox shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Lumox's last funding round?
Lumox's most recent funding round was Grant on July 16, 2026.
Who are the main investors in Lumox?
Key investors in Lumox include KWF Dutch Cancer Society, Philips Innovation Award, Utrecht Holdings.
Will Lumox IPO soon?
No public IPO plans have been announced for Lumox.
How can I track Lumox secondary market activity?
Caplight tracks bids, offers, and trades in Lumox's shares on secondary markets.